Purchase Order 75N92025P00388
Award Date
9/29/25
Potential Completion Date
9/28/26
Potential Value
$232K
Funding Federal Agency
National Human Genome Research Institute
Contracting Federal Agency
National Heart Lung and Blood Institute
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $235,200 firm fixed-price purchase order awarded by the National Human Genome Research Institute, part of the National Institutes of Health within the Department of Health and Human Services, to Baylor Miraca Genetics Laboratories LLC (dba Baylor Genetics) for whole genome sequencing and clinical testing services in support of the Undiagnosed Disease Program (UDP). The contract has an ultimate completion date of August 22, 2025 and was awarded on August 23, 2024. No set-aside...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health, to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics. The $68,900.00 contract is for chromosomal microarray analysis services, with a period of performance through April 17, 2023. Baylor Genetics is a for-profit limited liability company that specializes in...
This federal contract award is for whole exome sequencing and whole genome sequencing laboratory testing services for the Naval Medical Center San Diego. The $227,275.00 firm fixed-price purchase order was awarded to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics, a for-profit limited liability company that specializes in clinical genetic testing and precision medicine. The contract has an ultimate completion date of September 30, 2029. Baylor Genetics has also been...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $317,775.00 firm fixed-price purchase order to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics, for the provision of genomics services to support the NIAID Centralized Sequencing Initiative related to the COVID-19 response. Baylor Genetics, a for-profit genetics testing laboratory, has previously provided various...
This federal contract award to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics, is for $982,402.00 in Germline PGx Molecular Testing services. The award was made by the Department of Veterans Affairs (VA) Strategic Acquisition Center Frederick on September 30, 2024, with a period of performance through September 29, 2025. This is a firm fixed-price delivery order contract with no set-aside designation. Baylor Genetics is a for-profit limited liability company that...
This is a $11,387,675.00 Firm Fixed Price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center in Frederick, MD to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics. The contract is for "GERMLINE PGX MOLECULAR TESTING - YEAR 2" and has an ultimate completion date of September 29, 2026. Baylor Genetics is a for-profit limited liability company that specializes in clinical genetic testing and precision...
This is a $44,250 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics. The contract is for microarray testing services to support NIAID's infectious disease research, which aligns with the NIH's mission of advancing medical research to improve public health. This contract is not associated with a larger...
Baylor Genetics was awarded a $59,000 purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide clinical single nucleotide polymorphism and comparative genomic hybridization microarray testing services. The firm fixed price contract runs from July 14, 2023 through September 30, 2023 and will be performed in Houston, Texas. No subcontractors or set aside designations were identified. The testing services align with NIH's mission to...
This is a $730,306.58 firm-fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Baylor College of Medicine. The contract provides genetic testing services, including whole exome sequencing, comparative genomic hybridization, and whole genome sequencing coupled with RNA sequencing, in support of NIAID's Centralized Sequencing Initiative to obtain genetic testing...
Baylor Genetics will provide custom microarray sample testing services to the National Institute of Allergy and Infectious Diseases (NIAID) under a $32,550 firm fixed-price purchase order. As the prime contractor, Baylor Genetics will perform the work at its facilities in Houston, Texas to support NIAID's research efforts. No subcontractors or set-aside designations were identified. NIAID is a part of the National Institutes of Health within the Department of Health and Human Services, which...